Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

GCVRZ - Sanofi Contingent Value Rights 2011-31.12.20


Previous close
0.88
0   0%

Share volume: 0
Last Updated: Tue 03 Mar 2020 06:00:00 AM CET
Pharmaceuticals: Major: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$0.88
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
59%
Profitability 75%
Dept financing 25%
Liquidity 25%
Performance 60%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.88
P/E Ratio 
N/A
DAY RANGE
$0.88 - $0.88
EPS 
$0.00
52 WEEK RANGE
$0.20 - $0.60
52 WEEK CHANGE
$20.00
MARKET CAP 
652.000 M
YIELD 
N/A
SHARES OUTSTANDING 
1.254 B
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$34,408
AVERAGE 30 VOLUME 
$53,242
Company detail
CEO: Paul Hudson
Region: US
Website: http://www.sanofi.com
Employees: 0
IPO year: -
Issue type:
Market: NASDAQ
Industry: Pharmaceuticals: Major
Sector: Health Technology

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Recent news